The Effect of Coronavirus Disease 2019 on Reproduction System and Fertility
Keywords:COVID-19, pregnancy, fertility
As of October 9, 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was recorded to have infected more than 235 countries and 36,361,054 people globally, and 1,056,186 people died from coronavirus disease 2019 (COVID-19). In early October 2020, it was reported that the rate of increase in new cases reached 300,000 cases per day. A scientific reference source about COVID-19 in pregnancy and fertility system based on the results of previous research. By conducting a literature search that was carried out until October 12, 2020, through the PubMed and Google Scholar databases using the keyword COVID-19 and pregnancy, 20 articles were used as a reference source. Human SARS-CoV appeared in China, causing a deadly epidemic 18 years ago. Novel coronavirus-2019 infects target cells by binding to angiotensin-converting enzyme 2 (ACE2) through its surface spike protein. nCoV-2 modulates ACE2 expression and causes serious injury, similar to SARS-CoV. There is the possibility that the SARS-CoV-2 mechanism can affect fertility on female, namely, SARS-CoV-2 can harm ovarian tissue and granulosa cells, and reduce ovarian function and quality of oocytes, and can make infertility or miscarriage; also damage the endometrial epithelium and affect early embryo implantation. COVID-19 is caused by SARS-CoV-2 which is an acute infectious disease that mostly affects the respiratory system, but can also attack the reproductive system.
Plum Analytics Artifact Widget Block
Stanley KE, Thomas E, Leaver M, Wells D. Coronavirus disease (COVID- 19) and fertility: Viral host entry protein expression in male and female reproductive tissues. Fertil Steril. 2020;114(1):33-43. https://doi.org/10.1016/j.fertnstert.2020.05.001 PMid:32622411 DOI: https://doi.org/10.1016/j.fertnstert.2020.05.001
Jing Y, Run-Qian L, Hao-Ran W, Hao-Ran C, Ya-Bin L, Yang G, et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020;26(6):367-73. https://doi.org/10.1093/molehr/gaaa030 PMid:32365180 DOI: https://doi.org/10.1093/molehr/gaaa030
World Health Organization, WHO Coronavirus Disease (COVID-19) Dashboard. Geneva: World Health Organization; 2020. Available from: https://www.covid19.who.int/table. [Last accessed on 2021 May 26].
Satuan Tugas Penanganan COVID-19. Situasi Virus COVID-19 di Indonesia; 2020. Available from: https://www.covid19.go.id. [Last accessed on 2021 May 26].
Dinas Kesehatan Kota Medan. Data Generaal Terkait COVID- 19 di Kota Medan. 2020. Available from: https://www.covid19. pemkomedan.go.id/index.php?page=statmd. [Last accessed on 2021 May 26].
Zupin L, Pascolo L, Zito G, Ricci G, Crovella S. SARS-CoV-2 and the next generations: Which impact on reproductive tissues? J Assist Reprod Genet. 2020;37(10):2399-403. https://doi.org/10.1007/s10815-020-01917-0 PMid:32783136 DOI: https://doi.org/10.1007/s10815-020-01917-0
Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors lessons from available evidence and insights into COVID-19. Hypertens Res. 2020;43:648-54. https://doi.org/10.1038/s41440-020-0455-8 DOI: https://doi.org/10.1038/s41440-020-0455-8
Khalili MA, Leisegang K, Majzoub A, Finelli R, Selvam MK, Henkel R, et al. Male fertility and the COVID-19 pandemic: Systematic review of the literature. World J Mens Health. 2020;38(4):506-20. https://doi.org/10.5534/wjmh.200134 PMid:32814369 DOI: https://doi.org/10.5534/wjmh.200134
Illiano E, Trama F, Costantini E. Could COVID-19 have an impact on male fertility? Andrologia. 2020;52(6):e13654. https://doi.org/10.1111/and.13654 PMid:32436229 DOI: https://doi.org/10.1111/and.13654
Pascolo L, Zito G, Zupin L, Luppi S, Giolo E, Martinelli M, et al. Renin angiotensin system, COVID-19 and male fertility: Any risk for conceiving? Microorganisms. 2020;8(10):1492. https://doi.org/10.3390/microorganisms8101492 PMid:32998451 DOI: https://doi.org/10.3390/microorganisms8101492
Li R, Yin T, Fang F, Li Q, Chen J, Wang Y, et al. Potential risks of SARS-Cov-2 infection on reproductive health. Reprod Biomed Online. 2020;41(1):89-95. https://doi.org/10.1016/j.rbmo.2020.04.018 PMid:32466994 DOI: https://doi.org/10.1016/j.rbmo.2020.04.018
Goad J, Rudolph J, Rajkovic A. Female reproductive tract has low concentration of SARS-CoV2 receptors. bioRxiv. 2020;2020:163097. https://doi.org/10.1101/2020.06.20.163097 PMid:32607512 DOI: https://doi.org/10.1101/2020.06.20.163097
Chiofalo B, Baiocco E, Mancini E, Vocaturo G, Cutillo G, Vincenzoni C, et al. Practical recommendations for gynecologic surgery during the COVID-19 pandemic. Int J Gynecol Obstet. 2020;150(2):146-50. https://doi.org/10.1002/ijgo.13248 DOI: https://doi.org/10.1002/ijgo.13248
Grimes CL, Balk EM, Crisp CC, Antosh DD, Murphy M, Halder GE, et al. A guide for urogynecologic patient care utilizing telemedicine during the COVID-19 pandemic: Review of existing evidence. Int Urogynecol J. 2020;31(6):1063-89. https://doi.org/10.1007/s00192-020-04314-4 PMid:32342112 DOI: https://doi.org/10.1007/s00192-020-04314-4
Jnr BA. Use of telemedicine and virtual care for remote treatment in response to COVID-19 pandemic. J Med Syst. 2020;44(7):132. https://doi.org/10.1007/s10916-020-01596-5 PMid:32542571 DOI: https://doi.org/10.1007/s10916-020-01596-5
Indonesian Association of Obstetrics and Gynecology. POGI’s Telemedicine Guide in Recommendations for Corona Virus (COVID-19). Indonesia: Indonesian Association of Obstetrics and Gynecology; 2020
Telemedicine Indonesia; 2020. Available from: https://www. temenin.kemkes.go.id/#. [Last accessed on 2020 Oct 13].
Vidal-Alaball J, Acosta-Roja R, Hernández NP, Luque US, Morrison D, Pérez SN, et al. Telemedicine in the face of the COVID-19 pandemic. Aten Primaria. 2020;52(6):418-22. https://doi.org/10.1016/j.aprim.2020.04.003 PMid:32402477 DOI: https://doi.org/10.1016/j.aprim.2020.04.003
Veiga A, Gianaroli L, Ory S, Horton M, Feinberg E, Penzias A. Assisted reproduction and COVID-19: A joint statement of ASRM, ESHRE and IFFS∗. Fertil Steril. 2020;114(3):484-5. https://doi.org/10.1016/j.fertnstert.2020.06.044 PMid:32674808 DOI: https://doi.org/10.1016/j.fertnstert.2020.06.044
Alviggi C, Esteves SC, Orvieto R, Conforti A, La Marca A, Fischer R, et al. COVID-19 and assisted reproductive technology services: Repercussions for patients and proposal for individualized clinical management. Reprod Biol Endocrinol. 2020;18(1):45. PMid:32404170 DOI: https://doi.org/10.1186/s12958-020-00605-z
Barra F, La Rosa VL, Vitale SG, Commodari E, Altieri M, Scala C, et al. Impact of COVID-19 pandemic on the psychological status of infertile patients who had in vitro fertilization treatment interrupted or postponed: A cross-sectional study. Authorea Preprints. 2020. https://doi.org/10.22541/au.159809461.19005892 DOI: https://doi.org/10.22541/au.159809461.19005892
Siregar MF. Perimenopausal and postmenopausal complaints in paramedics assesed by menopause rating scale in Indonesia. J Dent Med Sci. 2014;13(12):38-42. https://doi.org/10.9790/0853-131213842 DOI: https://doi.org/10.9790/0853-131213842
ESHRE Covid-19 Working Group. ESHRE Guidance for Recommencing ART Treatments. ESHRE Website; 2020.
Peivandi S, Razavi A, Shafiei S, Zamaniyan M, Orafaie A, Jafarpour H. Evaluation of attitude among infertile couples about continuing assisted reproductive technologies therapy during novel coronavirus outbreak. medRxiv. 2020; https://doi.org/10.1101/2020.09.01.20186320 DOI: https://doi.org/10.1101/2020.09.01.20186320
Turocy JM, Robles A, Hercz D, D’alton M, Forman EJ, Williams Z. The emotional impact of the ASRM guidelines on fertility patients during the Covid-19 pandemic. Medrxiv. 2020. https://doi.org/10.1101/2020.03.29.20046631368 DOI: https://doi.org/10.1101/2020.03.29.20046631
How to Cite
Copyright (c) 2021 Muhammad Fidel Ganis Siregar, Effinia Kamila Hanum Siregar (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.